Skip to content

Clinical trials

Phase 1 Prostatic Hyperplasia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Phase 1 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20082
20112
20121
20141
20151
20161
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
Cancer Targeted Technology1
Johns Hopkins University1
Light Sciences Oncology1
The University of Texas Health Science Center, Houston1
University of California, Irvine1
University of North Carolina, Chapel Hill1
Urological Research Network, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia12
Lower Urinary Tract Symptoms2
Prostatic Neoplasms2
Genital Diseases, Male1
Male Urogenital Diseases1
Prostatic Diseases1
Urinary Bladder Neck Obstruction1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.